Legacy Capital Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-11,050
Closed -$272K 131
2018
Q1
$272K Hold
11,050
0.14% 108
2017
Q4
$297K Sell
11,050
-800
-7% -$20.3K 0.15% 101
2017
Q3
$285K Buy
11,850
+2,000
+20% +$45.2K 0.15% 100
2017
Q2
$211K Buy
+9,850
New +$199K 0.11% 109
2016
Q4
Sell
-14,580
Closed -$304K 113
2016
Q3
$304K Buy
14,580
+200
+1% +$4.96K 0.19% 98
2016
Q2
$387K Sell
14,380
-140
-1% -$3.84K 0.24% 91
2016
Q1
$394K Sell
14,520
-100
-0.7% -$2.68K 0.25% 86
2015
Q4
$425K Sell
14,620
-200
-1% -$5.54K 0.27% 80
2015
Q3
$402K Hold
14,820
0.27% 82
2015
Q2
$406K Sell
14,820
-600
-4% -$16.9K 0.26% 86
2015
Q1
$412K Buy
15,420
+820
+6% +$18.9K 0.26% 82
2014
Q4
$309K Buy
14,600
+1,160
+9% +$25.9K 0.2% 93
2014
Q3
$321K Sell
13,440
-3,200
-19% -$73.6K 0.21% 85
2014
Q2
$385K Sell
16,640
-1,600
-9% -$35.3K 0.25% 80
2014
Q1
$417K Sell
18,240
-2,300
-11% -$49K 0.3% 73
2013
Q4
$380K Sell
20,540
-12,000
-37% -$209K 0.27% 77
2013
Q3
$551K Buy
32,540
+1,950
+6% +$32.8K 0.41% 66
2013
Q2
$475K Buy
+30,590
New +$509K 0.36% 69

Other funds holding NVO